Could a cell therapy free some from daily insulin shots?
NCT ID NCT05791201
First seen May 14, 2026 · Last updated May 14, 2026
Summary
This early-stage trial tests VX-264, a cell therapy designed to help people with type 1 diabetes who have had the condition for at least 5 years. The main goals are to check safety and see if the treatment can improve the body's own insulin production. About 7 participants will be closely monitored, and while some may reduce or stop insulin temporarily, lifelong medication may still be needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Churchill Hospital
Headington, United Kingdom
-
Dresden Center for Islet Transplantation
Dresden, Germany
-
Hopiteaux Universitaires de Geneve
Geneva, Switzerland
-
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
IRCCS Ospedale San Raffaele
Milan, Italy
-
Leiden University
Leiden, Netherlands
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Montreal Clinical Research Institute
Montreal, Canada
-
Royal Victoria Infirmary
Newcastle upon Tyne, United Kingdom
-
Toronto General Hospital (TGH)
Toronto, Canada
-
UHealth Diabetes Research Institute
Miami, Florida, 33136, United States
-
University of Alberta, Edmonton
Edmonton, Canada
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Pittsburgh Medical Center Montefiore
Pittsburgh, Pennsylvania, 15213, United States
-
University of Wisconsin
Madison, Wisconsin, 53792, United States
-
Vancouver General Hospital
Vancouver, Canada
Conditions
Explore the condition pages connected to this study.